COMMUNIQUÉS West-GlobeNewswire

Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
30/05/2024
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today [...]
Revolutionary Beverage that Reduces Blood Alcohol Content Safety Shot partners with BM distributors to expand market presence in Las Vegas
30/05/2024
The Partnership Aims to Grow Market Reach In the Region and Enhance Accessibility JUPITER, FL, May 30, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company), announced today its strategic partnership [...]
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
30/05/2024
Sharps will strengthen its manufacturing capacity with a $35 million acquisition of assets, establishing the Company’s position in the specialized copolymer prefillable syringe (PFS) system industry in the U.S. Through [...]
Inozyme Pharma to Present at the Jefferies Global Healthcare Conference
30/05/2024
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of [...]
BioPorto A/S Appoints Chief Financial Officer
30/05/2024
May 30, 2024 Announcement no. 12 BioPorto A/S Appoints Chief Financial Officer BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced the appointment of Niels Høy Nielsen as its new Executive Vice President (EVP) and [...]
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
30/05/2024
FOSTER CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small molecule product [...]
Expanding retirement security for Ontario’s healthcare workers: HOOPP welcomes 35 new employers to the plan in 2023
30/05/2024
TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- HOOPP was pleased to welcome 35 new employers, including hospices, community care and family health teams, to the Plan in 2023. As one of the strongest, lowest cost and most [...]
INmune Bio Inc. to Join Russell 3000® Index
30/05/2024
Boca Raton, Florida, May 30, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, is set to join the broad-market Russell 3000 ® Index at the [...]
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis at 47ᵗʰ European Cystic Fibrosis Conference
30/05/2024
Interim clinical data will be presented by Jennifer L. Taylor-Cousar, M.D., Principal Investigator of the AEROW clinical trial at the 47 th European Cystic Fibrosis Conference on Thursday, June 6, 2024 at 5:00 p.m. BST [...]
Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
30/05/2024
TAMPA, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 [...]
Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference
30/05/2024
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to [...]
LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference
30/05/2024
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop [...]
Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
30/05/2024
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human [...]
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
30/05/2024
DUBLIN, May 30, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will [...]
Prime Medicine to Present at Upcoming Investor Conferences
30/05/2024
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]
ImCheck to Present Promising ICT01 Data from the EVICTION Study at ASCO 2024
30/05/2024
ImCheck to Present Promising ICT01 Data from the EVICTION Study at ASCO 2024 Interim data from Phase I/II EVICTION study shows favorable safety profile and promising efficacy for ICT01 in combination with pembrolizumab [...]
Humacyte to Present at the Jefferies Global Healthcare Conference
30/05/2024
DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today [...]
New study identifies higher risk of depression and anxiety among young men, gay or bisexual, and racialized Canadian men
30/05/2024
43% of young men aged 19-29 are at risk of depression Moderate-to-high anxiety impacts 57% of young men, 45% of gay or bisexual men, and 42% of racialized men National study from the Canadian Men’s Health Foundation [...]
ORYZON to Provide Corporate Progress Updates at Several Events in June
30/05/2024
BIO International Convention 2024 European Hematology Association (EHA) 2024 European Network to Cure ALS (ENCALS) 2024 MADRID and CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: [...]

Pages